List of Tables
Table 1. Global Medical Alpha Radionuclide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Medical Alpha Radionuclide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Medical Alpha Radionuclide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medical Alpha Radionuclide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Medical Alpha Radionuclide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global Medical Alpha Radionuclide Sales by Region (2020-2025) & (kg)
Table 8. Global Medical Alpha Radionuclide Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Medical Alpha Radionuclide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 11. Global Medical Alpha Radionuclide Production by Region (2020-2025) & (kg)
Table 12. Global Medical Alpha Radionuclide Production by Region (2026-2031) & (kg)
Table 13. Global Medical Alpha Radionuclide Sales by Manufacturers (2020-2025) & (kg)
Table 14. Global Medical Alpha Radionuclide Sales Share by Manufacturers (2020-2025)
Table 15. Global Medical Alpha Radionuclide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Medical Alpha Radionuclide Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Medical Alpha Radionuclide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Alpha Radionuclide as of 2024)
Table 19. Global Medical Alpha Radionuclide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Medical Alpha Radionuclide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
Table 21. Key Manufacturers Medical Alpha Radionuclide Manufacturing Base and Headquarters
Table 22. Global Medical Alpha Radionuclide Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Medical Alpha Radionuclide Sales by Type (2020-2025) & (kg)
Table 26. Global Medical Alpha Radionuclide Sales by Type (2026-2031) & (kg)
Table 27. Global Medical Alpha Radionuclide Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Medical Alpha Radionuclide Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Medical Alpha Radionuclide ASP by Type (2020-2031) & (US$/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Medical Alpha Radionuclide Sales by Application (2020-2025) & (kg)
Table 32. Global Medical Alpha Radionuclide Sales by Application (2026-2031) & (kg)
Table 33. Medical Alpha Radionuclide High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Medical Alpha Radionuclide Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Medical Alpha Radionuclide Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Medical Alpha Radionuclide ASP by Application (2020-2031) & (US$/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Medical Alpha Radionuclide Growth Accelerators and Market Barriers
Table 40. North America Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Medical Alpha Radionuclide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Medical Alpha Radionuclide Growth Accelerators and Market Barriers
Table 43. Europe Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Medical Alpha Radionuclide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Medical Alpha Radionuclide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Medical Alpha Radionuclide Growth Accelerators and Market Barriers
Table 48. Southeast Asia Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Medical Alpha Radionuclide Investment Opportunities and Key Challenges
Table 50. Central and South America Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Medical Alpha Radionuclide Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Medical Alpha Radionuclide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. ORNL Corporation Information
Table 54. ORNL Description and Major Businesses
Table 55. ORNL Product Models, Descriptions and Specifications
Table 56. ORNL Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 57. ORNL Sales Value Proportion by Product in 2024
Table 58. ORNL Sales Value Proportion by Application in 2024
Table 59. ORNL Sales Value Proportion by Geographic Area in 2024
Table 60. ORNL Medical Alpha Radionuclide SWOT Analysis
Table 61. ORNL Recent Developments
Table 62. Tri-Lab Corporation Information
Table 63. Tri-Lab Description and Major Businesses
Table 64. Tri-Lab Product Models, Descriptions and Specifications
Table 65. Tri-Lab Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 66. Tri-Lab Sales Value Proportion by Product in 2024
Table 67. Tri-Lab Sales Value Proportion by Application in 2024
Table 68. Tri-Lab Sales Value Proportion by Geographic Area in 2024
Table 69. Tri-Lab Medical Alpha Radionuclide SWOT Analysis
Table 70. Tri-Lab Recent Developments
Table 71. SSC RF-IPPE Corporation Information
Table 72. SSC RF-IPPE Description and Major Businesses
Table 73. SSC RF-IPPE Product Models, Descriptions and Specifications
Table 74. SSC RF-IPPE Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. SSC RF-IPPE Sales Value Proportion by Product in 2024
Table 76. SSC RF-IPPE Sales Value Proportion by Application in 2024
Table 77. SSC RF-IPPE Sales Value Proportion by Geographic Area in 2024
Table 78. SSC RF-IPPE Medical Alpha Radionuclide SWOT Analysis
Table 79. SSC RF-IPPE Recent Developments
Table 80. JRC Karlsruhe Corporation Information
Table 81. JRC Karlsruhe Description and Major Businesses
Table 82. JRC Karlsruhe Product Models, Descriptions and Specifications
Table 83. JRC Karlsruhe Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 84. JRC Karlsruhe Sales Value Proportion by Product in 2024
Table 85. JRC Karlsruhe Sales Value Proportion by Application in 2024
Table 86. JRC Karlsruhe Sales Value Proportion by Geographic Area in 2024
Table 87. JRC Karlsruhe Medical Alpha Radionuclide SWOT Analysis
Table 88. JRC Karlsruhe Recent Developments
Table 89. TerraPower Corporation Information
Table 90. TerraPower Description and Major Businesses
Table 91. TerraPower Product Models, Descriptions and Specifications
Table 92. TerraPower Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. TerraPower Sales Value Proportion by Product in 2024
Table 94. TerraPower Sales Value Proportion by Application in 2024
Table 95. TerraPower Sales Value Proportion by Geographic Area in 2024
Table 96. TerraPower Medical Alpha Radionuclide SWOT Analysis
Table 97. TerraPower Recent Developments
Table 98. TRIUMF Corporation Information
Table 99. TRIUMF Description and Major Businesses
Table 100. TRIUMF Product Models, Descriptions and Specifications
Table 101. TRIUMF Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 102. TRIUMF Recent Developments
Table 103. Eckert&Ziegler Corporation Information
Table 104. Eckert&Ziegler Description and Major Businesses
Table 105. Eckert&Ziegler Product Models, Descriptions and Specifications
Table 106. Eckert&Ziegler Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 107. Eckert&Ziegler Recent Developments
Table 108. Ionetix Corporation Information
Table 109. Ionetix Description and Major Businesses
Table 110. Ionetix Product Models, Descriptions and Specifications
Table 111. Ionetix Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 112. Ionetix Recent Developments
Table 113. Orano Med Corporation Information
Table 114. Orano Med Description and Major Businesses
Table 115. Orano Med Product Models, Descriptions and Specifications
Table 116. Orano Med Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 117. Orano Med Recent Developments
Table 118. National Nuclear Laboratory Corporation Information
Table 119. National Nuclear Laboratory Description and Major Businesses
Table 120. National Nuclear Laboratory Product Models, Descriptions and Specifications
Table 121. National Nuclear Laboratory Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 122. National Nuclear Laboratory Recent Developments
Table 123. NorthStar Corporation Information
Table 124. NorthStar Description and Major Businesses
Table 125. NorthStar Product Models, Descriptions and Specifications
Table 126. NorthStar Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 127. NorthStar Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Alpha Radionuclide Product Picture
Figure 2. Global Medical Alpha Radionuclide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Actinium-225 Product Picture
Figure 4. Astatine-211 Product Picture
Figure 5. Lead-212 Product Picture
Figure 6. Bismuth-213 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Medical Alpha Radionuclide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Immunotherapy
Figure 10. Peritoneal Carcinomas
Figure 11. Bone Metastases
Figure 12. Leukaemia
Figure 13. Melanomas
Figure 14. Solid Tumours
Figure 15. Medical Alpha Radionuclide Report Years Considered
Figure 16. Global Medical Alpha Radionuclide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 18. Global Medical Alpha Radionuclide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 19. Global Medical Alpha Radionuclide Revenue Market Share by Region (2020-2031)
Figure 20. Global Medical Alpha Radionuclide Sales (2020-2031) & (kg)
Figure 21. Global Medical Alpha Radionuclide Sales (CAGR) by Region (2020-2031) (kg)
Figure 22. Global Medical Alpha Radionuclide Sales Market Share by Region (2020-2031)
Figure 23. Global Medical Alpha Radionuclide Capacity, Production and Utilization (2020-2031) & (kg)
Figure 24. Global Medical Alpha Radionuclide Production Trend by Region (2020-2031) (kg)
Figure 25. Global Medical Alpha Radionuclide Production Market Share by Region (2020-2031)
Figure 26. Production Capacity Enablers & Constraints
Figure 27. Medical Alpha Radionuclide Production Growth Rate in North America (2020-2031) & (kg)
Figure 28. Medical Alpha Radionuclide Production Growth Rate in Europe (2020-2031) & (kg)
Figure 29. Medical Alpha Radionuclide Production Growth Rate in China (2020-2031) & (kg)
Figure 30. Medical Alpha Radionuclide Production Growth Rate in Japan (2020-2031) & (kg)
Figure 31. Top 5 and Top 10 Manufacturers Medical Alpha Radionuclide Sales Volume Market Share in 2024
Figure 32. Global Medical Alpha Radionuclide Revenue Market Share Ranking (2024)
Figure 33. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 34. Actinium-225 Revenue Market Share by Manufacturer in 2024
Figure 35. Astatine-211 Revenue Market Share by Manufacturer in 2024
Figure 36. Lead-212 Revenue Market Share by Manufacturer in 2024
Figure 37. Bismuth-213 Revenue Market Share by Manufacturer in 2024
Figure 38. Others Revenue Market Share by Manufacturer in 2024
Figure 39. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 40. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 41. Global Medical Alpha Radionuclide Sales Market Share by Type (2020-2031)
Figure 42. Global Medical Alpha Radionuclide Revenue Market Share by Type (2020-2031)
Figure 43. Global Medical Alpha Radionuclide Sales Market Share by Application (2020-2031)
Figure 44. Global Medical Alpha Radionuclide Revenue Market Share by Application (2020-2031)
Figure 45. North America Medical Alpha Radionuclide Sales YoY (2020-2031) & (kg)
Figure 46. North America Medical Alpha Radionuclide Revenue YoY (2020-2031) & (US$ Million)
Figure 47. North America Top 5 Manufacturers Medical Alpha Radionuclide Sales Revenue (US$ Million) in 2024
Figure 48. North America Medical Alpha Radionuclide Sales Volume (kg) by Type (2020- 2031)
Figure 49. North America Medical Alpha Radionuclide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 50. North America Medical Alpha Radionuclide Sales Volume (kg) by Application (2020-2031)
Figure 51. North America Medical Alpha Radionuclide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. US Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 53. Canada Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 54. Mexico Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 55. Europe Medical Alpha Radionuclide Sales YoY (2020-2031) & (kg)
Figure 56. Europe Medical Alpha Radionuclide Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Europe Top 5 Manufacturers Medical Alpha Radionuclide Sales Revenue (US$ Million) in 2024
Figure 58. Europe Medical Alpha Radionuclide Sales Volume (kg) by Type (2020-2031)
Figure 59. Europe Medical Alpha Radionuclide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 60. Europe Medical Alpha Radionuclide Sales Volume (kg) by Application (2020-2031)
Figure 61. Europe Medical Alpha Radionuclide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 62. Germany Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 63. France Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 64. U.K. Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 65. Italy Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 66. Russia Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 67. Asia-Pacific Medical Alpha Radionuclide Sales YoY (2020-2031) & (kg)
Figure 68. Asia-Pacific Medical Alpha Radionuclide Revenue YoY (2020-2031) & (US$ Million)
Figure 69. Asia-Pacific Top 8 Manufacturers Medical Alpha Radionuclide Sales Revenue (US$ Million) in 2024
Figure 70. Asia-Pacific Medical Alpha Radionuclide Sales Volume (kg) by Type (2020- 2031)
Figure 71. Asia-Pacific Medical Alpha Radionuclide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 72. Asia-Pacific Medical Alpha Radionuclide Sales Volume (kg) by Application (2020-2031)
Figure 73. Asia-Pacific Medical Alpha Radionuclide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 74. Indonesia Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 75. Japan Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 76. South Korea Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 77. China Taiwan Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 78. India Medical Alpha Radionuclide Revenue (2020-2031) & (US$ Million)
Figure 79. Central and South America Medical Alpha Radionuclide Sales YoY (2020-2031) & (kg)
Figure 80. Central and South America Medical Alpha Radionuclide Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Central and South America Top 5 Manufacturers Medical Alpha Radionuclide Sales Revenue (US$ Million) in 2024
Figure 82. Central and South America Medical Alpha Radionuclide Sales Volume (kg) by Type (2021-2031)
Figure 83. Central and South America Medical Alpha Radionuclide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Central and South America Medical Alpha Radionuclide Sales Volume (kg) by Application (2020-2031)
Figure 85. Central and South America Medical Alpha Radionuclide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. Brazil Medical Alpha Radionuclide Revenue (2020-2025) & (US$ Million)
Figure 87. Argentina Medical Alpha Radionuclide Revenue (2020-2025) & (US$ Million)
Figure 88. Middle East, and Africa Medical Alpha Radionuclide Sales YoY (2020-2031) & (kg)
Figure 89. Middle East and Africa Medical Alpha Radionuclide Revenue YoY (2020-2031) & (US$ Million)
Figure 90. Middle East and Africa Top 5 Manufacturers Medical Alpha Radionuclide Sales Revenue (US$ Million) in 2024
Figure 91. Middle East and Africa Medical Alpha Radionuclide Sales Volume (kg) by Type (2021-2031)
Figure 92. South America Medical Alpha Radionuclide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 93. Middle East and Africa Medical Alpha Radionuclide Sales Volume (kg) by Application (2020-2031)
Figure 94. Middle East and Africa Medical Alpha Radionuclide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 95. GCC Countries Medical Alpha Radionuclide Revenue (2020-2025) & (US$ Million)
Figure 96. Turkey Medical Alpha Radionuclide Revenue (2020-2025) & (US$ Million)
Figure 97. Egypt Medical Alpha Radionuclide Revenue (2020-2025) & (US$ Million)
Figure 98. South Africa Medical Alpha Radionuclide Revenue (2020-2025) & (US$ Million)
Figure 99. Medical Alpha Radionuclide Industry Chain Mapping
Figure 100. Regional Medical Alpha Radionuclide Manufacturing Base Distribution (%)
Figure 101. Medical Alpha Radionuclide Production Process
Figure 102. Regional Medical Alpha Radionuclide Production Cost Structure
Figure 103. Channels of Distribution (Direct Vs Distribution)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
